ABBV vs AMAT: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Applied Materials, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Applied Materials, Inc. · Technology
$394.33
-58.9% upside to fair value
Grade C
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+4.5%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMAT |
| Current Price |
$208.05 |
$394.33 |
| Fair Value Estimate |
$217.50 |
$162.08 |
| Upside to Fair Value |
+4.5%
|
-58.9%
|
| Market Cap |
$367.9B |
$312.9B |
| Forward P/E |
14.9x
|
39.9x
|
| EV / EBITDA |
16.7x
|
31.6x
|
| Price / Sales |
6.1x
|
11.1x
|
| Price / FCF |
20.9x
|
50.5x
|
| Revenue Growth YoY |
+8.6%
|
-2.1%
|
| Gross Margin |
83.7%
|
48.7%
|
| Operating Margin |
34.7%
|
29.1%
|
| Return on Equity |
-129.24%
|
38.9%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
1.98%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Applied Materials, Inc. is a leading global provider of semiconductor and display equipment, specializing in materials engineering solutions critical to chip manufacturing. The company benefits from a durable competitive moat supported by its market leadership, innovation engine with over 8,500 patents since 2013, and a strong management team led by CEO Gary E. Dickerson. Despite these strengths,…
Accumulation Zones
| Metric |
ABBV |
AMAT |
| Zone Low |
$163.13 |
$121.56 |
| Zone High |
$184.88 |
$137.77 |
| In Buy Zone? |
No
|
No
|